NEU 0.07% $15.13 neuren pharmaceuticals limited

Acadia, page-555

  1. 3,839 Posts.
    lightbulb Created with Sketch. 653
    I wish Acadia would tell us how many centres of excellence haven’t yet got on board yet, and how many haven’t yet but plan to in the next few months…. And how many Rett patients each of those support?

    Also, how many insurance companies haven’t agreed to pay up and how many haven’t yet but plan to?



    can anyone work it out?

    it would be good to know what percentage of patients are comfortably sitting at the recommended dose after, say,two months of settling in.

    I think investors would like to hear about lots of KPIs rather than just revenue figures from Acadia…is Acadia being patronising here, or cagey?



    ….
    Also was the market surprised to hear that onboarding Canada would still be at least 18 months from now?

    And that Europe would be at least two years away?

    I was…especially the Canada delay…






 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.13
Change
-0.010(0.07%)
Mkt cap ! $1.933B
Open High Low Value Volume
$15.04 $15.30 $14.96 $6.401M 422.6K

Buyers (Bids)

No. Vol. Price($)
1 1 $15.12
 

Sellers (Offers)

Price($) Vol. No.
$15.16 6015 1
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.